Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q2 2020 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2020-08-07

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 7, 2020

Total Value: $163M (100.0% shares, 0.0% debt)

Holdings (4)

PHAT PHATHOM PHARMACEUTICALS INC 41.8%

Value $68.05M Shares 2,067,861 Est. Cost $25.13 Unrealized +52.9%

PCVX VAXCYTE INC 36.7%

Value $59.66M Shares 1,887,478 Est. Cost $32.16 Unrealized 0.0%

— MERUS N V 15.8%

Value $25.74M Shares 1,600,000 Est. Cost $14.08 Unrealized —

— OBSEVA SA 5.7%

Value $9.247M Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$68.05M	41.8%	$25.13	+52.9%	COM	71722W107
PCVX	VAXCYTE INC	1,887,478	$59.66M	36.7%	$32.16	0.0%	COM	92243G108
—	MERUS N V	1,600,000	$25.74M	15.8%	$14.08	—	COM	N5749R100
—	OBSEVA SA	1,570,000	$9.247M	5.7%	$3.82	—	COM	H5861P103